Clinical Trial Update: Metformin And Chloroquine in IDH1/2-mutated Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating metformin and chloroquine in IDH1/2-mutated solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Chondrosarcoma
• Glioma

Drugs mentioned

• Chloroquine (chloroquine)
• metformin (metformin)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Glioma, Cholangiocarcinoma | Phase 1, Phase 2 | Status: COMPLETED